PNC Financial Services Group’s Organogenesis Holdings ORGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ORGO
PNC Financial Services Group's ORGO Position: Q3 2026 in Review
PNC Financial Services Group increased its Organogenesis Holdings (ORGO) stake by 7,339% in Q3 2026, buying an estimated $6.34K and bringing the position to 3,273 shares worth $4.48K. The position accounts for ﹤0.01% of the portfolio, ranked #4551.
PNC Financial Services Group first reported a position in ORGO in Q2 2021 and has held it in 14 quarters since. The position peaked at $42K in Q4 2021. 54 funds tracked by Wall St. Rank hold ORGO as of Q3 2026.
- PNC Financial Services Group held 3,273 shares of Organogenesis Holdings worth $4.48K as of Q3 2026.
- PNC Financial Services Group bought 3,229 Organogenesis Holdings shares in Q3 2026, an estimated $6.34K.
- Organogenesis Holdings made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #4551 holding.
- PNC Financial Services Group first reported a position in Organogenesis Holdings in Q2 2021 and has held it in 14 quarters since.
- PNC Financial Services Group's Organogenesis Holdings position peaked at $42K in Q4 2021.
- 54 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2026.
Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.